Investigator
Jonathan Himmelfarb, MD
What is the WAK Study?
The first U.S. trial of the Wearable Artificial Kidney looked at the safety and effectiveness of the device to deliver dialysis therapy at least equal to existing dialysis machines that deliver thrice-weekly in-center hemodialysis treatments.
